Friday, September 30, 2016

PharmaBro Martin Shkreli Is Auctioning Off The Chance To Punch Him In The Face

Anyone have $78,000 we can borrow?
From: NewNowNext
 There are a lot of people who would like to sock Martin Shkreli in the kisser, and now someone will get the chance.


The former pharmaceutical company CEO, who outraged millions by raising the price of an AIDS drug more than 5000%, is auctioning off the chance to punch him in the face for charity.









Shkreli went on Twitter Monday and announced one lucky (and wealthy) bidder could pay to punch or slap him in the face, with proceeds benefiting the family of Mike Kulich, his recently deceased PR rep.

Kulich, 29, died suddenly last week, leaving behind a fiancé and a young son who survived cancer.

Shkreli says he’s already received bids for $25,500 and $78,000.

In December, the former head of Turing Pharmaceuticals, was arrested on securities fraud charges. His trial has been set for June 26, 2017.





Florida Woman Wins Right to Punch Martin Shkreli in the Deplorable Face

From: Towleroad
Loathsome former Turing Pharmaceuticals CEO Martin Shkreli, who made headlines last fall after jacking the price of an AIDS drug by 5400%, this week auctioned off the right to punch him in the face.

Shkreli held the auction to raise money for treatment for a friend’s 6-year-old son who is battling cancer (maybe his heart isn’t 100% coal?).

A woman named Katie from Florida won the auction. Shkreli offered to broadcast it on VICE media if they were willing.


In September 2015, Shkreli, a former hedge fund manager, hiked the price of Daraprim, used to help (among others) AIDS patients with compromised immune systems, from $13.50 a tablet to $750 per tablet. Turing announced it had raised $90 million from Shkreli and other investors in its first round of financing on the same day as the pricejacking.

Shkreli promised to drop the price of Daraprim shortly after public outcry but his solution pleased few.

And despite pledging to cut its price, Turing Pharmaceuticals announced it would only provide discounts of up to 50 percent, for hospitals. Shkreli later said he regretted that he hadn’t charged even more for the drug.

In February, Shkreli appeared before the House Oversight Committee for a hearing on drug pricing. He was escorted from the room after refusing to speak, asserting his Fifth Amendment rights.

No comments:

Post a Comment